Miriam Haak, Director Business Development at Miltenyi Biotec GmbH, is responsible for the evaluation and establishment of partnership programs in the context of Miltenyi Biotec’s lentiviral vector and cell manufacturing services. She worked as an immunologist at the Max-Planck-Institute for Immunology in Freiburg, did her PhD in molecular oncology at the University of Muenster and worked at the PT-DLR in managing and developing funding priorities for the Federal Ministry of Education and Research.
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.